Neurological disorders affecting the central nervous system (CNS) are still incompletely
understood. Many of these disorders lack a cure and are seeking more specific and effective …

The etiology of many neurological diseases affecting the central nervous system (CNS) is
unknown and still needs more effective and specific therapeutic approaches. Gene therapy …

Neurological disorders–disorders of the brain, spine and associated nerves–are a leading
contributor to global disease burden with a shockingly large associated economic cost …

Current clinical treatments for central nervous system (CNS) diseases, such as Parkinson's
disease and glioblastoma do not halt disease progression and have significant treatment …

The era of the aging society has arrived, and this is accompanied by an increase in the
absolute numbers of patients with neurological disorders, such as Alzheimer's disease (AD) …

Gene therapy for neurological disorder is currently an experimental concept. The goals for
clinical utilization are the relief of symptoms, slowing of disease progression, and correction …

Diseases of the central nervous system (CNS) have traditionally been the most difficult to
treat by traditional pharmacological methods, due mostly to the blood–brain barrier and the …

Many chronic neurologic diseases do not respond to small molecule therapeutics, and have
no effective long-term therapy. Gene therapy offers the promise of an effective cure for both …

Gene therapy is a new method with potential for treating a broad range of acquired and
inherited neurologic diseases, where the causative gene defect or deletion has been …

Gene therapy aims at transferring a therapeutic gene into human somatic cells in order to
treat a disease. Originally addressed to hereditary genetic disorders, gene therapy has …